45
Participants
Start Date
December 31, 2008
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
3% tetracaine HCL with 0.05% oxymetazoline HCL
1 sham injection along with 3 sprays of Kovacaine Nasal Spray in each nostril; a 4-minute interval between every set of sprays. The total dose of 3% tetracaine HCL with 0.05% oxymetazoline HCL was 18 mg/0.3 mg.
Lidocaine Injection
Each subject received both an injection along with 3 sprays of isotonic saline sham in each nostril; a 4-minute interval between every set of sprays.
University of Buffalo, Buffalo
Collaborators (1)
Ground Zero Pharmaceuticals
INDUSTRY
Rho, Inc.
INDUSTRY
St. Renatus, LLC
INDUSTRY